Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.

Sebastian WurthBettina KuenzGabriel BstehRainer EhlingFranziska Di PauliHarald HegenMichael AuerViktoria GredlerFlorian DeisenhammerMarkus ReindlThomas Berger

Published in: PloS one (2017)

We detected significant differences in the CSF B cell subsets between different clinical MS subtypes and OND patients. CSF B cells were neither predictive for disease and EDSS progression nor conversion to CDMS after a CIS.

Keyphrases

multiple sclerosis
cerebrospinal fluid
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
ms ms
peripheral blood
patient reported outcomes